Coblopasvir

• CAT Number: I025054
• CAS Number: 1312608-46-0
• Molecular Formula: C41H50N8O8
• Molecular Weight: 782.89
• Purity: 98%
• Synonyms: Coblopasvir
• Target: Metabolic Enzyme/Protease
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: methyl N-[(2S)-1-[(2S)-2-[5-[4-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-1,3-benzodioxol-4-yl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
• InChI: InChI=1S/C41H50N8O8/c1-22(2)32(46-40(52)54-5)38(50)48-17-7-9-30(48)36-42-19-28(44-36)25-13-11-24(12-14-25)26-15-16-27(35-34(26)56-21-57-35)29-20-43-37(45-29)31-10-8-18-49(31)39(51)33(23(3)4)47-41(53)55-6/h11-16,19-20,22-23,30-33H,7-10,17-18,21H2,1-6H3,(H,42,44)(H,43,45)(H,46,52)(H,47,53)/t30-,31-,32-,33-/m0/s1
• InChIKey: JBYJTCVXUMWTJJ-YRCZKMHPSA-N
• SMILES: CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=C5C(=C(C=C4)C6=CN=C(N6)[C@@H]7CCCN7C(=O)[C@H](C(C)C)NC(=O)OC)OCO5)NC(=O)OC

Coblopasvir（Cat No.:I025054）is an investigational antiviral agent targeting the hepatitis C virus (HCV). As a potent NS5A inhibitor, it disrupts the viral replication complex, effectively halting RNA synthesis and viral assembly. Coblopasvir demonstrates broad-spectrum activity across multiple HCV genotypes, making it a promising candidate for inclusion in combination therapies aimed at achieving sustained virologic response. Its high potency and resistance barrier position it as a valuable tool in advancing HCV research. Coblopasvir contributes to the development of optimized antiviral regimens for managing chronic HCV infections effectively.